MedPath

A pilot study to determine the effects of sodium bicarbonate on urinary pH in patients at risk of contrast induced nephropathy.

Completed
Conditions
Patients at risk of contrast induced nephropathy.
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12609000550202
Lead Sponsor
Austin Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

Patients at risk of contrast induced nephropathy

Exclusion Criteria

Inability to provide written consent.
Patient requires an urgent coronary angiogram.
Pregnancy.
Breastfeeding.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rine pH (measured using a pH meter pen, Digitech)[After commencement of therapy (at next bladder void)]
Secondary Outcome Measures
NameTimeMethod
Serum creatinine (via blood analysis)[Within 48 hours of contrast administration]
© Copyright 2025. All Rights Reserved by MedPath